On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma
Clinical trial NCT06503211 · UNKNOWN
Trial details
- NCT number
- NCT06503211
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2025-07-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.